Could The Market Be Wrong About Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Its Attractive Financial Prospects?

Simply Wall StDec 23 18:59

H.C. Wainwright Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $75

Futu NewsDec 18 20:34 · Ratings

Harmony Biosciences Analyst Ratings

BenzingaDec 17 22:18 · Ratings

H.C. Wainwright Initiates Harmony Biosciences(HRMY.US) With Buy Rating, Announces Target Price $75

Futu NewsDec 17 21:31 · Ratings

Express News | Harmony Biosciences : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $75

BreakingsDec 17 21:12

Piper Sandler Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Raises Target Price to $48

Futu NewsDec 6 01:31 · Ratings